Moderna unsure of COVID-19 vaccine patent exclusivity

US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Moderna in dispute with US govt over COVID-19 vaccine inventors

11 November 2021 Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

Big Pharma

Dems pressure Biden to share Moderna vaccine tech

14 October 2021 A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

Big Pharma

WHO plans to vaccinate Africa with Moderna COVID vaccine hit stumbling block

16 September 2021 Just 12 African countries have hit WHO’s 10% vaccination target as supply chain issues worsen.